<DOC>
	<DOCNO>NCT00443846</DOCNO>
	<brief_summary>Primary objective : To check RotaTeq® administer concomitantly meningococcal Group C vaccine without impair efficacy MCC vaccine . Secondary objective : - Efficacy : Additional immunogenicity assessment . - Safety : To describe safety profile RotaTeq® MCC vaccine administer concomitantly RotaTeq® .</brief_summary>
	<brief_title>RotaTeq® Meningococcus C Vaccine Healthy Infants</brief_title>
	<detailed_description />
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Rotavirus Infections</mesh_term>
	<mesh_term>Meningitis , Meningococcal</mesh_term>
	<criteria>Healthy infant , age 6 week full 7 week , Consent form sign least one parent legal representative properly inform study , Parent ( ) / legal representative able understand protocol requirement fill Diary Card . History congenital abdominal disorder , congenital malformation gastrointestinal tract could predispose intussusception , abdominal surgery , Congenital fructose intolerance , glucosegalactose malabsorption sucraseisomaltase insufficiency , Known suspect impairment immunological function , Known hypersensitivity component RotaTeq® ( e.g . sucrose ) NeisVacC® ( include tetanus toxoid ) , Prior administration rotavirus vaccine , Prior administration vaccine within 28 day prior randomisation , Fever ( rectal temperature ≥38.1°C ) and/or acute diarrhoea and/or vomit randomisation , History know prior rotavirus gastroenteritis , chronic diarrhoea , failure thrive , Any severe thrombocytopenia coagulation disorder would contraindicate intramuscular injection , Clinical evidence active gastrointestinal illness , Receipt intramuscular , oral , intravenous corticosteroid treatment within 14 day prior randomisation . Note : Infants inhale and/or topical steroid may participate study , Infants reside household immunocompromised person , Prior receipt blood transfusion blood product , include immunoglobulin .</criteria>
	<gender>All</gender>
	<minimum_age>42 Days</minimum_age>
	<maximum_age>56 Days</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Prevention Gastroenteritis due rotavirus infection . And prevention Invasive disease cause Neisseria meningitidis serogroup C .</keyword>
</DOC>